Kit Simpson to Disease-Free Survival
This is a "connection" page, showing publications Kit Simpson has written about Disease-Free Survival.
Connection Strength
0.082
-
Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Clin Lymphoma Myeloma. 2008 Jun; 8(3):166-70.
Score: 0.072
-
Presentation, survival and prognostic markers in AA amyloidosis. QJM. 2000 Aug; 93(8):535-42.
Score: 0.010